Wisconsin Biohealth Summit

It Takes a Village: Perspectives on the Biologic/Novel Modality Drug Development Journey

Moving next-generation and biologic therapies through the pipeline and to market is highly complex and fraught with risk. New targets and modalities emerge almost daily. It’s critical to quickly develop scalable processes that are aligned with pre-clinical, clinical, and commercial requirements for safety, manufacturability, and market access.

Our distinguished panelists will share their perspectives on current best-in-class approaches to facilitating scale-up transitions and give insight on how to leverage CRO, CDMO, and industry collaboration to improve and de-risk the development process.